Behind the Mystery: Understanding Pheochromocytoma and Paraganglioma
February 28, 2019
Learn About Pheochromocytoma and Paraganglioma, Known As Rare Neuroendocrine Tumors
Understanding Pheochromocytoma and Paraganglioma; rare neuroendocrine tumors that can dramatically impact survival in people of all ages. Every year in the US, fewer than 8 out of one million people are diagnosed with pheo or para tumors. But as many as 130,000 people are living with the disease in the US, although that number may be higher due to underdiagnosis. If pheo and para tumors are not diagnosed and appropriately treated, the disease will likely be fatal Dr. Joseph Dillon, Co-Director of the Neuroendocrine Tumor Clinic at the University of Iowa educates us on these rare tumors, symptoms to be aware of, and how patients should proceed if they are diagnosed.
BioTE Medical is a leader in precision and preventive medicine. They create patient-centric strategies that optimize hormones for women and men.
The Oxford Gold Group was founded on the belief that everyone should have the opportunity to afford and benefit from owning precious metals. They tailor investment strategies for each investor based on their specific needs.
TruSculpt iD and truSculpt flex offer you a total body solution to remove fat, renew skin, and rebuild muscle.